Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

STO/CINPHA stock hub

STO/CINPHA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/CINPHAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

559.4M

Nasdaq Stockholm

Market data

Live price

Current market quote for this ticker.

Current price

STO/CINPHA

In the news

Latest news · STO/CINPHA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-39.8

P25 n/aP50 n/aP75 n/a

ROIC-26.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/CINPHA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

161

Groups with data

Currency

SEK

Showing 161 of 161 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	21
Employees Change	3%
Employees Change Percent	16.67
Enterprise value	SEK 80M
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	SE0020388577
Last refreshed	2026-05-10
Market cap	SEK 559.4M
Price	SEK 12.02
Price currency	SEK
Rev Per Employee	2,736,666.67x
Sector	Healthcare
Sic	2834
Symbol	sto/CINPHA
Website	https://cincluspharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-32.89%
EV Earnings	-0.44x
EV/FCF	-1.06x
EV/Sales	1.39x
FCF yield	-13.55%
P/B ratio	1.51x
P/S ratio	9.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	SEK 57.5M
Gross Profit Growth	1,154.8%
Gross Profit Growth Q	197.62%
Net Income	SEK -184M
Pretax Margin	-319.66%
Profit Per Employee	SEK -8.8M
ROA	-21.59
Roa5y	-49.94
ROCE	-48.36
ROE	-39.79
Roe5y	-242.2
ROIC	-26.55

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	27.49%
Revenue Growth	1,154.8x
Revenue Growth Q	197.62x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.1
Assets	SEK 546.6M
Cash	SEK 487.3M
Current Assets	SEK 536.9M
Current Liabilities	SEK 136.8M
Debt	SEK 7.9M
Debt Equity	SEK 0.02
Debt FCF	SEK -0.1
Equity	SEK 369.4M
Interest Coverage	-501.7
Liabilities	SEK 177.2M
Long Term Assets	SEK 9.7M
Long Term Liabilities	SEK 40.4M
Net Cash	SEK 479.4M
Net Cash By Market Cap	SEK 85.69
Net Cash Growth	-15.37%
Net Debt Equity	SEK -1.3
Tangible Book Value	SEK 369.4M
Tangible Book Value Per Share	SEK 7.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.92
Net Working Capital	SEK -84.1M
Quick ratio	3.72
Working Capital	SEK 400.1M
Working Capital Turnover	SEK 0.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-25.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	27.47%
200-day SMA	16.82
50-day SMA	15.86
50-day SMA vs 200-day SMA	50under200
All Time High	40
All Time High Change	-69.95%
All Time High Date	2024-06-20
All Time Low	9.31
All Time Low Change	29.11%
All Time Low Date	2025-05-07
ATR	0.8
Beta1y	1.05
Beta2y	0.7
Ch YTD	-37.59
High	12.4
High52	19.64
High52 Date	2026-01-05
High52ch	-38.8%
Low	11.9
Low52	9.4
Low52 Date	2025-05-08
Low52ch	27.87%
Ma50ch	-24.23%
Price vs 200-day SMA	-28.55%
RSI	30.07
RSI Monthly	29.42
RSI Weekly	29.73
Sharpe ratio	0.48x
Sortino ratio	1.15
Total Return	-25.69%
Tr YTD	-37.59
Tr1m	-22.95%
Tr1w	2.04%
Tr3m	-28.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -198.2M
Operating margin	-344.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	34,308,592%
Net Borrowing	-1,760,000
Shares Insiders	11.04%
Shares Institutions	28.75%
Shares Out	46,537,789
Shares Qo Q	0%
Shares Yo Y	25.69%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK -79M
Average Volume	273,504.05x
Bv Per Share	7.94
CAPEX	SEK -1.1M
Ch1m	-22.95
Ch1w	2.04
Ch1y	27.47
Ch3m	-28.71
Ch6m	-31.08
Change	-3.06%
Change From Open	-3.06
Close	12.4
Days Gap	0
Depreciation Amortization	132,000
Dollar Volume	1,065,176.3
Earnings Date	2026-04-16
EBIT	SEK -198.2M
EBITDA	SEK -198M
EPS	SEK -3.95
F Score	2
FCF	SEK -75.8M
FCF EV Yield	-94.69x
FCF Per Share	SEK -1.63
Financing CF	-1,760,000
Fiscal Year End	December
Founded	2,014
Income Tax	SEK 262,000
Investing CF	-1,429,000
Is Primary Listing	1
Last Earnings Date	2026-04-16
Last Report Date	2025-12-31
Ma150	16.91
Ma150ch	-28.91%
Ma20	14.08
Ma20ch	-14.65%
Net CF	-79,463,000
Next Earnings Date	2026-05-13
Open	12.4
Position In Range	24
Ppne	9,406,000
Price Date	2026-05-08
Ptbv Ratio	1.51
Relative Volume	0.32x
Revenue	57,470,000x
SBC By Revenue	5.52x
Share Based Comp	3,170,000
Tax By Revenue	0.46x
Tr6m	-31.08%
Volume	88,617
Z Score	-0.17

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STO/CINPHA pay a dividend?

Capital-return profile for this ticker.

Performance

STO/CINPHA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/CINPHA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+28.8%

Share of float held by funds and institutions

Insider ownership

+11.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+25.7%

Negative means the company is buying back shares.

Technical

STO/CINPHA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

30.1

Neutral momentum band

Price vs 200-day MA

-28.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.48

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/CINPHA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/CINPHA stock rating?

sto/CINPHA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/CINPHA analysis?

The full report lives at /stocks/sto/CINPHA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/CINPHA?

The latest report frames sto/CINPHA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/CINPHA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.